Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 446-451

  Garey, K W ^a,b   Lai, D ^c   Dao Tran, T K ^b   Gentry, L O ^b   Hwang, L Y ^c   Davis, B R ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORONARY ARTERY BYPASS GRAFT; DRUG SUBSTITUTION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART SURGERY; HEART VALVE SURGERY; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SURGICAL INFECTION;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFUROXIME; COAGULASE; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 38649100346     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00495-07     Document Type: Article

References (27)

1. Anonymous. 2001. Antimicrobial prophylaxis in surgery. Med. Lett. Drugs Ther. 43:92-97.
2. Anonymous. 2004. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32:470-485.
3. Ansari, F., K. Gray, D. Nathwani, G. Phillips, S. Ogston, C. Ramsay, and P. Davey. 2003. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J. Antimicrob. Chemother. 52:842-848.
4. Bolon, M. K., M. Morlote, S. G. Weber, B. Koplan, Y. Carmeli, and S. B. Wright. 2004. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin. Infect. Dis. 38:1357-1363.
5. Box, G. E. P., and G. C. Tiao. 1975. Intervention analysis with applications to economic and environmental problems. J. Am. Stat. Assoc. 70:70-92.
6. Bratzler, D. W., and P. M. Houck. 2004. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin. Infect. Dis. 38:1706-1715.
7. Centers for Disease Control and Prevention. 1997. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. Morb. Mortal. Wkly. Rep. 46:626-628, 635.
8. Chenoweth, C. E., D. D. DePestel, and R. L. Prager. 2005. Are cephalosporins adequate for antimicrobial prophylaxis for cardiac surgery involving implants? Clin. Infect. Dis. 41:122-123.
9. Diggle, P. J. 2000. Time series. A biostatistical introduction, 5th ed. Oxford University Press, New York, NY.
10. Finkelstein, R., G. Rabino, T. Mashiah, Y. Bar-El, Z. Adler, V. Kertzman, O. Cohen, and S. Milo. 2002. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J. Thorac. Cardiovasc. Surg. 123:326-332.
11. Garey, K. W., T. Dao, H. Chen, P. Amrutkar, N. Kumar, M. Reiter, and L. O. Gentry. 2006. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J. Antimicrob. Chemother. 58:645-650.
12. Harvey, A. 1996. Intervention analysis with control groups. Int. Stat. Rev. 64:313-328.
13. Horan, T. C., R. P. Gaynes, W. J. Martone, W. R. Jarvis, and T. G. Emori. 1992. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect. Control Hosp. Epidemiol. 13:606-608.
14. Kachroo, S., T. Dao, F. Zabaneh, M. Reiter, M. T. Larocco, L. O. Gentry, and K. W. Garey. 2006. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization. Ann. Pharmacother. 40:381-385.
15. Ljung, G. M., and G. E. P. Box. 1978. On a measure of lack of fit in time series models. Biometrika 65:297-303.
16. Maclayton, D. O., K. J. Suda, K. A. Coval, C. B. York, and K. W. Garey. 2006. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin. Ther. 28:1208-1216.
17. Maki, D. G., M. J. Bohn, S. M. Stolz, G. M. Kroncke, C. W. Acher, and P. D. Myerowitz. 1992. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J. Thorac. Cardiovasc. Surg. 104:1423- 1434.
18. McDowall, D. 1980. Interrupted time series analysis. Sage, Beverly Hills, CA.
19. Mekontso-Dessap, A., M. Kirsch, C. Brun-Buisson, and D. Loisance. 2001. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin. Infect. Dis. 32:877-883.
20. Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering, Jr. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
21. Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, and D. A. Talan. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
22. Murray, B. E. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:710-721.
23. Rice, L. B. 2006. Antimicrobial resistance in gram-positive bacteria. Am. J. Infect. Control 34:S11-S19.
24. Spelman, D., G. Harrington, P. Russo, and S. Wesselingh. 2002. Clinical, microbiological, and economic benefit of a change in antibiotic prophylaxis for cardiac surgery. Infect. Control Hosp. Epidemiol. 23:402-404.
25. Tenover, F. C., L. M. Weigel, P. C. Appelbaum, L. K. McDougal, J. Chai tram, S. McAllister, N. Clark, G. Killgore, C. M. O'Hara, L. Jevitt, J. B. Patel, and B. Bozdogan. 2004. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48:275-280.
26. Wagner, A. K., S. B. Soumerai, F. Zhang, and D. Ross-Degnan. 2002. Segmented regression analysis of interrupted time series studies in medication use research. J. Clin. Pharm. Ther. 27:299-309.
27. Yaffee, R. A., and M. McGee. 2000. Introduction to time series analysis and forecasting: with applications in SAS and SPSS. Academic Press, Inc., San Diego, CA.